SolventumSOLV
About: Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Employees: 22,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
29% more capital invested
Capital invested by funds: $5.65B [Q2] → $7.3B (+$1.65B) [Q3]
22% more funds holding in top 10
Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]
5% more first-time investments, than exits
New positions opened: 143 | Existing positions closed: 136
1% more funds holding
Funds holding: 887 [Q2] → 894 (+7) [Q3]
1.45% less ownership
Funds ownership: 61.87% [Q2] → 60.42% (-1.45%) [Q3]
26% less call options, than puts
Call options by funds: $48M | Put options by funds: $64.8M
59% less repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 415
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Morgan Stanley Patrick Wood 33% 1-year accuracy 3 / 9 met price target | 8%upside $73 | Equal-Weight Maintained | 11 Nov 2024 |
Piper Sandler Jason Bednar 46% 1-year accuracy 17 / 37 met price target | 11%upside $75 | Neutral Maintained | 8 Nov 2024 |
Stifel Rick Wise 74% 1-year accuracy 20 / 27 met price target | 22%upside $82 | Buy Initiated | 8 Oct 2024 |
Piper Sandler Jason Bednar 46% 1-year accuracy 17 / 37 met price target | 5%upside $71 | Neutral Initiated | 7 Oct 2024 |
Financial journalist opinion
Based on 9 articles about SOLV published over the past 30 days
